October 2011
U.S. Judicial Panel to decide on Actos MDL
- Fri, 10/28/2011 - 10:10am
- Comments
Actos® was released in July of 1999 and was intended for the purpose of increasing the body’s sensitivity to insulin in patients diagnosed with type II diabetes.
Actos attorneys clash with plaintiffs on behalf of consolidated litigation
- Mon, 10/17/2011 - 9:45am
- Comments
Actos, a type 2 diabetes medication often used instead Avandia, has been linked to bladder cancer.
Actos users file class action lawsuit against Takeda Pharmaceuticals
- Mon, 10/17/2011 - 9:42am
- Comments
Two users of type II diabetes drug Actos have filed a class action lawsuit against Takeda Pharmaceuticals, the makers of the drug, and Eli Lilly, strategic partner to Takeda.